CLINICAL_TRIALS
trial_result
· 2022-01-24
Clinical Trial Update: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine [Phase 2]
Summary
A Phase 2 multicenter trial evaluating LBR-101 for episodic migraine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Episodic Migraine Headache | Phase 2 | Status: COMPLETED | Results posted: 2022-01-24